WEKO3
アイテム
{"_buckets": {"deposit": "7905d8cd-eca4-4071-b680-aa27ea9c1b1c"}, "_deposit": {"created_by": 1, "id": "45201", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "45201"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00045201", "sets": ["1"]}, "author_link": ["448976", "448987", "448978", "448983", "448989", "448984", "448991", "448981", "448982", "448988", "448986", "448990", "448992", "448985", "448977", "448980", "448994", "448979", "448993"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2008-02", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "2", "bibliographicPageEnd": "212", "bibliographicPageStart": "203", "bibliographicVolumeNumber": "35", "bibliographic_titles": [{"bibliographic_title": "Nuclear Medicine and Biology"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "High-affinity iodine- and ethyl-C-5 substituted analogs of 4-hydroxy-3-(3-[11C]methoxyphenyl)-2(1H)-quinolone ([11C]4HQ) were synthesized as new positron emission tomography radioligands for the glycine-binding sites of the N-methyl-d-aspartate (NMDA) ion channel. Although both radioligands showed high in vitro specific binding to rat brain slices, their binding characteristics were quite different from each other. 5-Ethyl-[11C]4HQ (5Et-[11C]4HQ) showed higher in vitro binding in the forebrain regions than in the cerebellum, bindings that were strongly inhibited by both glycine-site agonists and antagonists. In contrast, 5-iodo-[11C]4HQ (5I-[11C]4HQ) showed a homogeneous in vitro binding throughout the brain, which was inhibited by antagonists but not by agonists. This difference in in vitro binding between 5Et-[11C]4HQ and 5I-[11C]4HQ was quite similar to that previously observed between [11C]L-703,717 and [11C]4HQ, both glycine-site antagonists. In vivo brain uptakes of these 11C-labeled 4-hydroxyquinolones were examined in mice. Initial brain uptakes of 5Et- and 5I-[11C]4HQ at 1 min after intravenous injections were comparable to that of [11C]4HQ, but they were 1.3-2.1 times higher than that of [11C]L-703,717. The treatment with an anticoagulant, warfarin, only slightly increased the initial uptakes of [11C]4HQ and 5Et-[11C]4HQ in contrast to [11C]L-703,717. The in vivo regional brain distributions were slightly different between the two radioligands. Pretreatment with nonradioactive ligand (2 mg/kg) slightly inhibited the binding of 5Et-[11C]4HQ (16-36% inhibition) but not that of 5I-[11C]4HQ. In this study, it was found that a small structural change in [11C]4HQ resulted in a major change in binding characteristics and distributions, suggesting the existence of two binding sites for [11C]4-hydroxyquinolones on the NMDA ion channel - agonist-sensitive and agonist-insensitive (or antagonist-preferring) sites.", "subitem_description_type": "Abstract"}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0969-8051", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Fuchigami, Takeshi"}], "nameIdentifiers": [{"nameIdentifier": "448976", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Haradahira, Terushi"}], "nameIdentifiers": [{"nameIdentifier": "448977", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Fujimoto, Noriko"}], "nameIdentifiers": [{"nameIdentifier": "448978", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Okauchi, Takashi"}], "nameIdentifiers": [{"nameIdentifier": "448979", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Maeda, Jun"}], "nameIdentifiers": [{"nameIdentifier": "448980", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Suzuki, Kazutoshi"}], "nameIdentifiers": [{"nameIdentifier": "448981", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Suhara, Tetsuya"}], "nameIdentifiers": [{"nameIdentifier": "448982", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamamoto, Fumihiko"}], "nameIdentifiers": [{"nameIdentifier": "448983", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Mukai, Takahiro"}], "nameIdentifiers": [{"nameIdentifier": "448984", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Magata, Yasuhiro"}], "nameIdentifiers": [{"nameIdentifier": "448985", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Maeda, Minoru"}], "nameIdentifiers": [{"nameIdentifier": "448986", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "et.al"}], "nameIdentifiers": [{"nameIdentifier": "448987", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "淵上 剛志", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "448988", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "原田平 輝志", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "448989", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "岡内 隆", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "448990", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "前田 純", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "448991", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "鈴木 和年", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "448992", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "須原 哲也", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "448993", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "前田 稔", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "448994", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Difference in brain distribustions of carbon 11-labeled 4-hydroxy-2(1H)-quinolones as PET radioligands for the glycine-binding site of the NMDA ion channel", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Difference in brain distribustions of carbon 11-labeled 4-hydroxy-2(1H)-quinolones as PET radioligands for the glycine-binding site of the NMDA ion channel"}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/45201", "pubdate": {"attribute_name": "公開日", "attribute_value": "2008-06-17"}, "publish_date": "2008-06-17", "publish_status": "0", "recid": "45201", "relation": {}, "relation_version_is_last": true, "title": ["Difference in brain distribustions of carbon 11-labeled 4-hydroxy-2(1H)-quinolones as PET radioligands for the glycine-binding site of the NMDA ion channel"], "weko_shared_id": -1}
Difference in brain distribustions of carbon 11-labeled 4-hydroxy-2(1H)-quinolones as PET radioligands for the glycine-binding site of the NMDA ion channel
https://repo.qst.go.jp/records/45201
https://repo.qst.go.jp/records/452015da55277-7ba1-4d9b-bac0-e77c0222c2a5
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2008-06-17 | |||||
タイトル | ||||||
タイトル | Difference in brain distribustions of carbon 11-labeled 4-hydroxy-2(1H)-quinolones as PET radioligands for the glycine-binding site of the NMDA ion channel | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Fuchigami, Takeshi
× Fuchigami, Takeshi× Haradahira, Terushi× Fujimoto, Noriko× Okauchi, Takashi× Maeda, Jun× Suzuki, Kazutoshi× Suhara, Tetsuya× Yamamoto, Fumihiko× Mukai, Takahiro× Magata, Yasuhiro× Maeda, Minoru× et.al× 淵上 剛志× 原田平 輝志× 岡内 隆× 前田 純× 鈴木 和年× 須原 哲也× 前田 稔 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | High-affinity iodine- and ethyl-C-5 substituted analogs of 4-hydroxy-3-(3-[11C]methoxyphenyl)-2(1H)-quinolone ([11C]4HQ) were synthesized as new positron emission tomography radioligands for the glycine-binding sites of the N-methyl-d-aspartate (NMDA) ion channel. Although both radioligands showed high in vitro specific binding to rat brain slices, their binding characteristics were quite different from each other. 5-Ethyl-[11C]4HQ (5Et-[11C]4HQ) showed higher in vitro binding in the forebrain regions than in the cerebellum, bindings that were strongly inhibited by both glycine-site agonists and antagonists. In contrast, 5-iodo-[11C]4HQ (5I-[11C]4HQ) showed a homogeneous in vitro binding throughout the brain, which was inhibited by antagonists but not by agonists. This difference in in vitro binding between 5Et-[11C]4HQ and 5I-[11C]4HQ was quite similar to that previously observed between [11C]L-703,717 and [11C]4HQ, both glycine-site antagonists. In vivo brain uptakes of these 11C-labeled 4-hydroxyquinolones were examined in mice. Initial brain uptakes of 5Et- and 5I-[11C]4HQ at 1 min after intravenous injections were comparable to that of [11C]4HQ, but they were 1.3-2.1 times higher than that of [11C]L-703,717. The treatment with an anticoagulant, warfarin, only slightly increased the initial uptakes of [11C]4HQ and 5Et-[11C]4HQ in contrast to [11C]L-703,717. The in vivo regional brain distributions were slightly different between the two radioligands. Pretreatment with nonradioactive ligand (2 mg/kg) slightly inhibited the binding of 5Et-[11C]4HQ (16-36% inhibition) but not that of 5I-[11C]4HQ. In this study, it was found that a small structural change in [11C]4HQ resulted in a major change in binding characteristics and distributions, suggesting the existence of two binding sites for [11C]4-hydroxyquinolones on the NMDA ion channel - agonist-sensitive and agonist-insensitive (or antagonist-preferring) sites. | |||||
書誌情報 |
Nuclear Medicine and Biology 巻 35, 号 2, p. 203-212, 発行日 2008-02 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0969-8051 |